Literature DB >> 9126220

Defining the ideal tumor marker for prostate cancer.

J E Montie1, S E Meyers.   

Abstract

The ideal tumor marker would function well for detection, screening, staging, prognosis, follow-up, and performance characteristics. Prostate-specific antigen is a remarkably good tool in this respect; however, the translation into improved patient outcomes is still uncertain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126220     DOI: 10.1016/s0094-0143(05)70369-4

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  2 in total

Review 1.  Regular review: tumour markers in malignancies.

Authors:  A Lindblom; A Liljegren
Journal:  BMJ       Date:  2000-02-12

2.  Increased discrimination between benign prostatic hyperplasia and prostate cancer with equimolar total prostate specific antigen measurement.

Authors:  R Onur; N Ilhan; I Orhan; N Ilhan
Journal:  World J Urol       Date:  2003-03-26       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.